Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C028474 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene affects the expression of NFIX mRNA | affects expression | 18281256
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of NFIX mRNA | affects expression | 21346803
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of NFIX mRNA | decreases expression | 18648102
|
C027576 |
4-hydroxy-2-nonenal |
4-hydroxy-2-nonenal results in decreased expression of NFIX mRNA | decreases expression | 12419474
|
C006780 |
bisphenol A |
bisphenol A inhibits the reaction [Triiodothyronine results in increased expression of NFIX mRNA] | decreases reaction|increases expression | 19228888
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of NFIX mRNA | decreases expression | 12419474
|
D019256 |
Cadmium Chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of NFIX mRNA | affects cotreatment|increases expression | 12634122
|
C023600 |
chromium oxide |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of NFIX mRNA | affects cotreatment|increases expression | 12634122
|
C017133 |
chromous chloride |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of NFIX mRNA | affects cotreatment|increases expression | 12634122
|
C014347 |
decitabine |
decitabine results in decreased expression of NFIX mRNA | decreases expression | 19363521
|
C014347 |
decitabine |
TP53 protein affects the reaction [decitabine results in decreased expression of NFIX mRNA] | affects reaction|decreases expression | 19363521
|
D004958 |
Estradiol |
Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of NFIX mRNA] | decreases reaction|increases expression | 16977382
|
D000431 |
Ethanol |
Ethanol results in decreased expression of NFIX mRNA | decreases expression | 15353170
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of NFIX mRNA | decreases expression | 17557909
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in decreased expression of NFIX mRNA | decreases expression | 15954086
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in decreased expression of NFIX mRNA | decreases expression | 12419474
|
C008261 |
lead acetate |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of NFIX mRNA | affects cotreatment|increases expression | 12634122
|
D001556 |
Lindane |
Lindane results in increased expression of NFIX mRNA | increases expression | 17785943
|
D008070 |
Lipopolysaccharides |
Estradiol inhibits the reaction [Lipopolysaccharides results in increased expression of NFIX mRNA] | decreases reaction|increases expression | 16977382
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of NFIX mRNA | increases expression | 16977382
|
D008345 |
Manganese |
Manganese results in decreased expression of NFIX mRNA | decreases expression | 17175027
|
C025340 |
manganese chloride |
manganese chloride results in decreased expression of NFIX mRNA | decreases expression | 17175027
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of NFIX mRNA | decreases expression | 20059764
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of NFIX mRNA] | decreases expression|increases reaction | 20059764
|
C035988 |
procymidone |
procymidone results in increased expression of NFIX mRNA | increases expression | 15686871
|
D011374 |
Progesterone |
Progesterone affects the expression of NFIX mRNA | affects expression | 17251523
|
C059514 |
resveratrol |
resveratrol results in increased expression of NFIX mRNA | increases expression | 12002526
|
C017947 |
sodium arsenite |
[sodium arsenite co-treated with Cadmium Chloride co-treated with chromium oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of NFIX mRNA | affects cotreatment|increases expression | 12634122
|
D014284 |
Triiodothyronine |
bisphenol A inhibits the reaction [Triiodothyronine results in increased expression of NFIX mRNA] | decreases reaction|increases expression | 19228888
|
D014284 |
Triiodothyronine |
Triiodothyronine results in increased expression of NFIX mRNA | increases expression | 19228888
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of NFIX mRNA | decreases expression | 15849065
|
C517826 |
tetrabrominated diphenyl ether 47 |
tetrabrominated diphenyl ether 47 results in decreased expression of NFIX mRNA | decreases expression | 20056577
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NFIX mRNA | decreases expression | 16054898
|
C025643 |
vinclozolin |
vinclozolin affects the expression of NFIX mRNA | affects expression | 19015723
|
C025643 |
vinclozolin |
vinclozolin results in increased methylation of NFIX intron | increases methylation | 16973722
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.26 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Ethanol |
7.54 | 18926900 17676605 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.54 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ethanol |
4.22 | 11192467 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.66 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.60 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
8.19 | 18653653 11850527 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.19 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
3.97 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
3.97 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
10.40 | 3712494 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
10.40 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
10.40 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
8.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.97 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.42 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.62 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Lindane |
4.10 | 12661182 |
MESH:D020268 |
Alcohol-Induced Disorders, Nervous System |
|
Ethanol |
5.03 | 15451040 15451039 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.51 | 16183991 16162502 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
3.93 | 10965797 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.71 | 11748828 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Manganese |
10.20 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
manganese chloride |
10.20 | 16910769 |
MESH:D000853 |
Anophthalmos |
|
Ethanol |
4.55 | 15513904 |
MESH:D001008 |
Anxiety Disorders |
|
Ethanol |
8.29 | 11141031 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
8.29 | 19015723 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.19 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.79 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.79 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.11 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
tetrabrominated diphenyl ether 47 |
3.40 | 19211157 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.73 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.94 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.94 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.51 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.59 | 15746008 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.61 | 11985600 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.64 | 14991843 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
5.05 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.98 | 15665606 15380490 15845082 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.00 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.05 | 16651633 16357521 16436596 18412241 15144691 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
4.49 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
4.49 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
4.49 | 14630087 17289903 16675129 17018787 17261762 18497071 19861407 12948864 |
MESH:D001943 |
Breast Neoplasms |
|
Lindane |
4.49 | 14688026 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
4.49 | 15562024 16175315 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
4.49 | 17534123 16393696 17651959 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
4.49 | 20544844 18984771 18351453 19066611 19289846 16273361 18629630 19244106 19189212 17049068 19221464 19487384 15668708 16818667 19115204 19200415 15565566 16873071 20135344 18821012 18855134 17242785 17893378 19103187 18425577 21138602 18815881 17261762 19155303 19288272 19142967 20005174 11161223 19410462 19189210 20390343 16202921 18997820 20859285 19011961 19084267 21152245 20065188 17440819 19059307 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
4.49 | 20435547 |
MESH:D002056 |
Burns |
|
Ethanol |
4.38 | 16374292 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.18 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.58 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.23 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
13.34 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
13.34 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
13.34 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Ethanol |
13.34 | 15289165 15763234 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
13.34 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.34 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.34 | 16924424 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.71 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.31 | 16675471 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.54 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
7.14 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
7.14 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.14 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.37 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Ethanol |
6.33 | 19332462 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.33 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
6.95 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
6.95 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
14.51 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
14.51 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
14.51 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
14.51 | 20056578 19524636 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.70 | 17160924 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
12.19 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.19 | 16105132 16919318 15861022 17110522 11677210 17681005 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.19 | 19176532 |
MESH:D002971 |
Cleft Lip |
|
Ethanol |
3.44 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Ethanol |
5.56 | 15513904 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.56 | 15340226 8697196 12621046 16354765 15668235 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.86 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
3.77 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
3.77 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.65 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
2.65 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 14669216 17141729 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.57 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Ethanol |
3.81 | 11198716 15513904 19302082 10194807 15451039 15451040 11873399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
3.81 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.81 | 10048152 20055451 15322242 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.07 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
3.74 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.09 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.54 | 12868966 2524372 8156756 11906362 18759878 14531868 8970840 11298694 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.30 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.23 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.55 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.60 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.68 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
13.68 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.68 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
4.22 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
8.26 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.26 | 11289319 6679447 9022650 16192314 9328219 18692083 8291058 7440962 18289764 6482804 18648102 1440618 9653073 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Ethanol |
8.26 | 11566570 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.26 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.56 | 11462148 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.70 | 18357618 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.00 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
10.00 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.00 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.62 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
19.74 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
19.74 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
19.74 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
19.74 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
4.83 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
6.79 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
6.79 | 16202921 20544844 17893378 19155303 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
8.13 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.13 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.12 | 15821434 15328337 17637181 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.57 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.38 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
Ethanol |
4.38 | 16704527 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.81 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethanol |
16.72 | 19236843 16409862 18620774 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
16.72 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
16.72 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
16.72 | 14986274 19224547 |
MESH:D005235 |
Fatty Liver, Alcoholic |
|
Ethanol |
5.38 | 17920746 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.07 | 16709447 |
MESH:D005310 |
Fetal Alcohol Syndrome |
|
Ethanol |
5.02 | 16946407 15451040 10194807 15513904 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.18 | 11858732 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
5.12 | 19769572 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.77 | 11852909 9205823 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.73 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.25 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.90 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
2.68 | 20067830 |
MESH:D005756 |
Gastritis |
|
Ethanol |
4.41 | 15046732 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.65 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.02 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.40 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
7.15 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Manganese |
7.15 | 17043766 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
3.38 | 18412241 16651633 16357521 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.78 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.31 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.30 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.18 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.37 | 20558911 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.14 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.09 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.25 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
1,4-bis(2-(3,5-dichloropyridyloxy))benzene |
12.97 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.97 | 19772884 16221962 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.97 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.75 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.90 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
2.93 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.47 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.76 | 15340226 16354765 8697196 18606429 16959395 |
MESH:D006930 |
Hyperalgesia |
|
Ethanol |
3.50 | 18783367 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.76 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.94 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.77 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.67 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.80 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.06 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.54 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
10.57 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
10.57 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.20 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
14.53 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
14.53 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
14.53 | 15346721 12646999 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
14.53 | 16467254 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
14.31 | 17963957 12878042 17255318 9205823 17237260 |
MESH:D007249 |
Inflammation |
|
Progesterone |
14.31 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
14.31 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
14.31 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
14.31 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
4.26 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
11.27 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
11.27 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
11.27 | 16306350 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.37 | 17255318 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.73 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Ethanol |
9.29 | 15513904 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.29 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Cadmium Chloride |
9.28 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
9.28 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
9.28 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.02 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
20.96 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
20.96 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
20.96 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
20.96 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
20.96 | 18625569 |
MESH:D007859 |
Learning Disorders |
|
Ethanol |
3.94 | 15451040 |
MESH:D007938 |
Leukemia |
|
decitabine |
2.93 | 19235587 18980019 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
3.75 | 18454857 17236224 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.33 | 17679729 19387464 18704418 18206229 18460780 19010910 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.18 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.40 | 16087638 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.42 | 15821434 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.45 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Ethanol |
3.62 | 17676605 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.96 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Ethanol |
3.22 | 15289165 |
MESH:D008104 |
Liver Cirrhosis, Alcoholic |
|
Ethanol |
4.82 | 18295389 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.02 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
8.25 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Ethanol |
8.25 | 18166357 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
8.25 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
8.25 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
8.25 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.25 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Lindane |
3.03 | 1715830 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Ethanol |
4.38 | 17207112 17347304 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.07 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
13.07 | 19073162 20405173 19812893 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.07 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
13.07 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.07 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
5.16 | 598648 3712494 6587162 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.16 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.99 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.74 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
4.58 | 17703301 16019985 16271038 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.58 | 17077188 17306315 19931552 16712894 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.58 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.58 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
decitabine |
7.25 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
7.25 | 15790496 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.04 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.65 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
4.77 | 15375218 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
9.07 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
9.07 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
16.94 | 16891317 11408345 11807958 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
16.94 | 10838139 10767621 18041768 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
16.94 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
16.94 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
16.94 | 19196722 14580682 19196723 16827153 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
20.74 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Manganese |
20.74 | 19453300 16568477 16551646 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
20.74 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
6.88 | 17785578 16505122 |
MESH:D008545 |
Melanoma |
|
resveratrol |
6.88 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
6.88 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
6.88 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
3.90 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Ethanol |
3.92 | 18411066 15451040 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.70 | 17943659 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.13 | 17112576 |
MESH:D009069 |
Movement Disorders |
|
Manganese |
4.75 | 16551646 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
6.86 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
6.86 | 17049120 16490592 14749477 16267019 17935668 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.59 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.23 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.22 | 18608210 19157545 19010910 16882708 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.35 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.35 | 17188708 16525036 17125593 16317513 16456233 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.28 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.28 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.55 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
7.55 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.48 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
3.58 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
5.31 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.31 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.42 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
10.76 | 19470736 19116145 17925555 |
MESH:D009369 |
Neoplasms |
|
Lindane |
10.76 | 16818664 12807735 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
10.76 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
10.76 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
13.81 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
13.81 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
13.81 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.72 | 19200415 19196722 19189210 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.45 | 17289903 |
MESH:D009410 |
Nerve Degeneration |
|
Manganese |
4.06 | 16551646 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
14.81 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.81 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.81 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
6.66 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
6.66 | 12854658 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.14 | 16003739 16651423 17160924 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.58 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.14 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.75 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
8.08 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.08 | 6482804 4026338 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.70 | 17160924 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.73 | 3988306 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.00 | 17513867 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.71 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
10.55 | 19331143 19259094 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.55 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
10.55 | 17393432 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
10.55 | 17306315 15276417 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.22 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Ethanol |
5.22 | 12384795 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.43 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
8.41 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
8.41 | 12065085 |
MESH:D010300 |
Parkinson Disease |
|
Manganese |
3.27 | 11181820 |
MESH:D020734 |
Parkinsonian Disorders |
|
Manganese |
4.23 | 16140633 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.96 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
12.05 | 6228378 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
12.05 | 11550810 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.27 | 11605937 12224865 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.29 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
20.95 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
20.95 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
20.95 | 11896295 11399792 11118676 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
20.95 | 19015723 18220299 18042343 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.45 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.65 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.72 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.72 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Lindane |
1.88 | 14688026 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
1.88 | 17675339 15767336 17804756 17718901 17636462 16731767 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.88 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.88 | 15067354 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.65 | 18629315 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.03 | 15861022 16919318 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.51 | 10548101 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.30 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.11 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.11 | 16317513 17520802 17058453 16314181 15827377 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.55 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.57 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.17 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.14 | 19155313 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.76 | 18045962 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
8.93 | 18551238 |
MESH:D012640 |
Seizures |
|
Ethanol |
8.93 | 9754883 |
MESH:D012640 |
Seizures |
|
Lindane |
8.93 | 7539098 12842176 15475178 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
16.52 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
16.52 | 15837718 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
16.52 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
16.52 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
16.52 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.61 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
10.61 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
9.94 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
9.94 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.58 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.66 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Ethanol |
2.66 | 18456281 |
MESH:D013276 |
Stomach Ulcer |
|
Ethanol |
3.29 | 9211565 17189318 17918041 16755016 9562338 11906479 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.24 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.71 | 16684133 16045194 |
MESH:D013375 |
Substance Withdrawal Syndrome |
|
Ethanol |
4.01 | 9754883 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.92 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.36 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.92 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
4.88 | 15790496 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.62 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.55 | 6582329 3712494 1399818 6587162 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
6.55 | 17967635 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.40 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
3.97 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
14.61 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
14.61 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
14.61 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
14.61 | 16452187 17306315 11723127 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
14.61 | 8653321 17572228 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.04 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
8.76 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
8.76 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.72 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.61 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
8.61 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.63 | 17785578 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.14 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.31 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.29 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.03 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.96 | 15886252 |